JP2013532662A5 - - Google Patents

Download PDF

Info

Publication number
JP2013532662A5
JP2013532662A5 JP2013520880A JP2013520880A JP2013532662A5 JP 2013532662 A5 JP2013532662 A5 JP 2013532662A5 JP 2013520880 A JP2013520880 A JP 2013520880A JP 2013520880 A JP2013520880 A JP 2013520880A JP 2013532662 A5 JP2013532662 A5 JP 2013532662A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
disease
amyloidosis
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013520880A
Other languages
English (en)
Japanese (ja)
Other versions
JP6042331B2 (ja
JP2013532662A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/044999 external-priority patent/WO2012012712A2/en
Publication of JP2013532662A publication Critical patent/JP2013532662A/ja
Publication of JP2013532662A5 publication Critical patent/JP2013532662A5/ja
Application granted granted Critical
Publication of JP6042331B2 publication Critical patent/JP6042331B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013520880A 2010-07-23 2011-07-22 プロテアソーム活性を向上させる三環系化合物 Expired - Fee Related JP6042331B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36717310P 2010-07-23 2010-07-23
US61/367,173 2010-07-23
PCT/US2011/044999 WO2012012712A2 (en) 2010-07-23 2011-07-22 Tricyclic proteasome activity enhancing compounds

Publications (3)

Publication Number Publication Date
JP2013532662A JP2013532662A (ja) 2013-08-19
JP2013532662A5 true JP2013532662A5 (https=) 2014-08-28
JP6042331B2 JP6042331B2 (ja) 2016-12-14

Family

ID=45497483

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013520880A Expired - Fee Related JP6042331B2 (ja) 2010-07-23 2011-07-22 プロテアソーム活性を向上させる三環系化合物

Country Status (7)

Country Link
US (3) US8933087B2 (https=)
EP (1) EP2595993B1 (https=)
JP (1) JP6042331B2 (https=)
CN (1) CN103119047B (https=)
AU (1) AU2011281015B2 (https=)
CA (1) CA2808432C (https=)
WO (1) WO2012012712A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120117905A (ko) * 2010-01-28 2012-10-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 프로테아좀 활성을 향상시키는 조성물 및 방법
EP2595993B1 (en) 2010-07-23 2018-04-18 President and Fellows of Harvard College Tricyclic proteasome activity enhancing compounds
WO2012097013A1 (en) 2011-01-10 2012-07-19 Nimbus Iris, Inc. Irak inhibitors and uses thereof
HUE044867T2 (hu) 2011-05-12 2019-11-28 Proteostasis Therapeutics Inc Proteosztázis szabályzók
JP6126131B2 (ja) 2012-01-10 2017-05-10 ニンバス アイリス, インコーポレイテッド Irak阻害剤およびその使用
EP2806875B1 (en) * 2012-01-25 2017-07-19 Proteostasis Therapeutics, Inc. Proteasome activity modulating compounds
WO2014011906A2 (en) 2012-07-11 2014-01-16 Nimbus Iris, Inc. Irak inhibitors and uses thereof
WO2014011902A1 (en) 2012-07-11 2014-01-16 Nimbus Iris, Inc. Irak inhibitors and uses thereof
EP2938610A2 (en) 2012-12-28 2015-11-04 The U.S.A. as represented by the Secretary, Department of Health and Human Services Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
CA2890911A1 (en) 2013-01-10 2014-07-17 Nimbus Iris, Inc. Irak inhibitors and uses thereof
US9849135B2 (en) 2013-01-25 2017-12-26 President And Fellows Of Harvard College USP14 inhibitors for treating or preventing viral infections
WO2014145576A2 (en) 2013-03-15 2014-09-18 Northwestern University Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer
CN106232122A (zh) 2013-09-27 2016-12-14 林伯士艾瑞斯公司 Irak抑制剂和其用途
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577420A (en) * 1968-01-05 1971-05-04 Pfizer Certain 4-aminofuro(2,3-d)pyrimidines
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
DD245666A1 (de) 1985-09-20 1987-05-13 Univ Halle Wittenberg Verfahren zur herstellung von 4-aminosubstituierten thieno 2,3-d-pyrimidin-2-ylessigsaeureestern
JPH01313480A (ja) 1988-06-14 1989-12-18 Nippon Soda Co Ltd ピリミジン誘導体、その製造方法及び農園芸用殺菌剤
WO1998029397A1 (en) 1996-12-27 1998-07-09 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrimidine compounds and medicinal use thereof
CN1346358A (zh) 1999-03-30 2002-04-24 日本曹达株式会社 噻吩并嘧啶化合物及其盐和制备方法
WO2000066585A1 (en) 1999-04-30 2000-11-09 Neurogen Corporation 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
JP2002105082A (ja) 2000-09-29 2002-04-10 Nippon Soda Co Ltd 縮合チエノピリミジン化合物、その塩及び製造法
DE10064994A1 (de) 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
HUP0302987A2 (hu) 2001-01-31 2003-12-29 Merck Patent Gmbh Pirazolo [4,3-d] pirimidinszármazékokat vagy tienopirimidinszármazékokat és nitrátvegyületeket tartalmazó gyógyászati készítmények
MXPA03009925A (es) * 2001-04-30 2004-06-30 Bayer Pharmaceuticals Corp Nuevas tiofeno [2,3-d]pirimidinas 4-amino-5,6-sustituidas.
DE10148883A1 (de) 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
JP2003137886A (ja) * 2001-10-31 2003-05-14 Bayer Ag ピリミド[4,5−b]インドール
JP2005515173A (ja) * 2001-10-31 2005-05-26 バイエル・ヘルスケア・アクチェンゲゼルシャフト ピリミド[4,5−b]インドール誘導体
WO2004041285A1 (en) 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
ES2217956B1 (es) 2003-01-23 2006-04-01 Almirall Prodesfarma, S.A. Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo.
NZ542236A (en) * 2003-03-31 2008-05-30 Predix Pharmaceuticals Holding New piperidinylamino-thieno[2,3-d]pyrimidine compounds
US7612078B2 (en) 2003-03-31 2009-11-03 Epix Delaware, Inc. Piperidinylamino-thieno[2,3-D] pyrimidine compounds
JP5249772B2 (ja) * 2005-11-22 2013-07-31 メルク・シャープ・アンド・ドーム・コーポレーション キナーゼの阻害剤として有用な三環式化合物
US7960400B2 (en) 2007-08-27 2011-06-14 Duquesne University Of The Holy Ghost Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
CA2699349C (en) 2007-09-14 2016-04-19 Bayer Schering Pharma Aktiengesellschaft Substituted tricyclic heterocyclic compounds for use as egfr inhibitors
US20100227853A1 (en) 2008-04-18 2010-09-09 Trustees Of Boston College Inhibitors of cyclic amp phosphodiesterases
US8507502B2 (en) 2008-11-10 2013-08-13 National Health Research Institutes Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
CN104856991A (zh) 2009-02-27 2015-08-26 西佳技术公司 用于治疗和预防登革热病毒感染的噻吩并吡啶衍生物
KR20120117905A (ko) 2010-01-28 2012-10-24 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 프로테아좀 활성을 향상시키는 조성물 및 방법
EP2595993B1 (en) 2010-07-23 2018-04-18 President and Fellows of Harvard College Tricyclic proteasome activity enhancing compounds
TW201219401A (en) 2010-09-14 2012-05-16 Lexicon Pharmaceuticals Inc Bicyclic inhibitors of Notum Pectinacetylesterase and methods of their use
CN102532159B (zh) 2010-11-12 2015-02-11 姚雪彪 动点马达蛋白CENP-E小分子抑制剂Syntelin
WO2012097013A1 (en) 2011-01-10 2012-07-19 Nimbus Iris, Inc. Irak inhibitors and uses thereof
JP6126131B2 (ja) 2012-01-10 2017-05-10 ニンバス アイリス, インコーポレイテッド Irak阻害剤およびその使用

Similar Documents

Publication Publication Date Title
JP2013532662A5 (https=)
JP2016147893A5 (https=)
JP2023500408A5 (https=)
RU2002124522A (ru) Производные 2-оксо-1-пирролидина, способ их получения и применения
KR20070085262A (ko) 신규한 피리디논 유도체 및 mGluR2-수용체의 양성알로스테릭 조절자로서 그것의 용도
RU2017142979A (ru) Замещенные циклические амиды и их применение в качестве гербицидов
JP2005502661A5 (https=)
DK0777652T3 (da) Neurobeskyttende 3-(piperidinyl-1)-chroman-4,7-diol-og 1-(4-hydrophenyl)-2-(piperidinyl-1)alkanolderivater
JP2009506039A5 (https=)
JP2003528859A5 (https=)
JP2018502148A5 (https=)
JP2011507893A5 (https=)
JP2010526145A5 (https=)
RU2009133794A (ru) Гербициды на основе замещенного n-оксида пиридина
JP2005520839A5 (https=)
RU2017134973A (ru) Бутиролактоны в качестве гербицидов
JP2018501226A5 (https=)
SI3075726T1 (en) DERIVATIVES OF UREA OR ITS PHARMACOLOGICAL RECRUITABLE SALTS USED AS FORMIL PEPTIDAL RECEPTOR LIKE 1 (FPRL-1) AGONISTS
JP2018524336A5 (https=)
RU2018103198A (ru) Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
RU97102362A (ru) Нейрозащитные производные 3-(пиперидинил-1)-хроман-4,7-диола и 1-(4- гидроксифенил)-2-(пиперидинил-1)-алканола
IL273000B2 (en) Compounds that inhibit lysophosphatidic acid receptor 1 (lpar1)
JP2011503006A5 (https=)
JP2020522496A5 (https=)
RU2000131184A (ru) Соединения, обладающие свойствами, способствующими выделению гормона роста